Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Truist Financial Analyst Says

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price hoisted by analysts at Truist Financial from $22.00 to $24.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s price target would suggest a potential upside of 8.94% from the stock’s current price.

Several other research analysts have also recently issued reports on SBRA. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Raymond James Financial initiated coverage on shares of Sabra Healthcare REIT in a report on Wednesday, June 17th. They set an “underperform” rating for the company. Scotiabank dropped their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Cantor Fitzgerald raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Trading Up 0.2%

Shares of SBRA stock opened at $22.03 on Wednesday. The business has a 50-day moving average of $19.64 and a 200 day moving average of $19.82. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT has a 1-year low of $17.17 and a 1-year high of $22.55. The stock has a market capitalization of $5.56 billion, a PE ratio of 34.97, a P/E/G ratio of 1.63 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the firm earned $0.37 EPS. The business’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds have recently made changes to their positions in SBRA. Vanguard Group Inc. lifted its stake in Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after acquiring an additional 481,231 shares during the period. Principal Financial Group Inc. increased its position in Sabra Healthcare REIT by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares during the period. Nuveen LLC increased its position in Sabra Healthcare REIT by 28.6% during the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after purchasing an additional 1,625,072 shares during the period. Geode Capital Management LLC raised its holdings in Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after purchasing an additional 198,118 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after purchasing an additional 447,528 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.